UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer

BMC cancer, 2024-08, Vol.24 (1), p.954-9, Article 954

2024

Volltextzugriff (PDF)

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

BMC cancer, 2023-10, Vol.23 (1), p.1-1045, Article 1045

2023

Volltextzugriff (PDF)

Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?

Future oncology (London, England), 2021-12, Vol.17 (35), p.4823-4825

2021

Volltextzugriff (PDF)

Clinical features and outcomes of COVID‐19 in patients with solid tumors: Turkish National Registry Data

International journal of cancer, 2021-05, Vol.148 (10), p.2407-2415

2021

Volltextzugriff (PDF)

Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy

Journal of cancer research and therapeutics, 2023-12, Vol.19 (Suppl 2), p.S845-S850

2023

Volltextzugriff (PDF)

Economic burden of lung cancer in Turkey: A cost of illness study from payer perspective

Health economics review, 2021-06, Vol.11 (1), p.1-12, Article 22

2021

Volltextzugriff (PDF)

Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme

Neuropathology, 2018-10, Vol.38 (5), p.457-462

2018

Volltextzugriff (PDF)

Prognostic Role of OX40, LAG-3, TIM-3 and PD-L1 Expression in Bone and Soft Tissue Sarcomas

Journal of clinical medicine, 2024-06, Vol.13 (12), p.3620

2024

Volltextzugriff (PDF)

Current status of biosimilars in Turkey: A survey among medical oncologists

Journal of oncology pharmacy practice, 2022-10, Vol.28 (7), p.1516-1523

2022

Volltextzugriff (PDF)

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

ESMO open, 2020-01, Vol.5 (3), p.e000698-e000698, Article e000698

2020

Volltextzugriff (PDF)

Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer

Annals of nuclear medicine, 2011-07, Vol.25 (6), p.406-413

2011

Volltextzugriff (PDF)

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

Japanese journal of clinical oncology, 2015-05, Vol.45 (5), p.416-421

2015

Volltextzugriff (PDF)

Combination therapies in non-clear-cell renal cell carcinoma

The lancet oncology, 2023-10, Vol.24 (10), p.e401-e401

2023

Volltextzugriff (PDF)

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Journal of clinical oncology, 2022-12, Vol.40 (34), p.4027-4027

2022

Volltextzugriff (PDF)

Thirty-day mortality rates after immunotherapy initiation

Immunotherapy, 2021-12, Vol.13 (17), p.1419-1426

2021

Volltextzugriff (PDF)

Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience

Journal of cancer research and therapeutics, 2020-12, Vol.16 (Supplement), p.S99-103

2020

Volltextzugriff (PDF)

Ribociclib-induced pulmonary infiltrates in a patient with breast cancer

Journal of oncology pharmacy practice, 2023-09, Vol.29 (6), p.1537-1540

2023

Volltextzugriff (PDF)

Evaluation of PIV Score as a Predictor Biomarker for Pathologically Proven Intermediate-High Risk Gastric Gastrointestinal Stromal Tumors

Eurasian journal of medical investigation, 2024, p.67-72

Unsal, Oktay

2024

Volltextzugriff (PDF)

Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life Experience

Türk onkoloji dergisi, 2023

yılmaz, mukaddes

2023

Volltextzugriff (PDF)

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Indian journal of cancer, 2021-10, Vol.58 (4), p.561-566

2021

Volltextzugriff (PDF)

Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

International urology and nephrology, 2014-06, Vol.46 (6), p.1081-1087

2014

Volltextzugriff (PDF)

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

Journal of clinical oncology, 2022-07, Vol.40 (19), p.JCO2200084-2178

2022

Volltextzugriff (PDF)

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

Journal of clinical oncology, 2023-01, Vol.41 (2), p.416-417

2023

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment?

Clinical features and outcomes of COVID‐19 in patients with solid tumors: Turkish National Registry Data

Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy

Economic burden of lung cancer in Turkey: A cost of illness study from payer perspective

Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme

Prognostic Role of OX40, LAG-3, TIM-3 and PD-L1 Expression in Bone and Soft Tissue Sarcomas

Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

Current status of biosimilars in Turkey: A survey among medical oncologists

A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study

Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites

Combination therapies in non-clear-cell renal cell carcinoma

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Thirty-day mortality rates after immunotherapy initiation

Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience

Ribociclib-induced pulmonary infiltrates in a patient with breast cancer

Evaluation of PIV Score as a Predictor Biomarker for Pathologically Proven Intermediate-High Risk Gastric Gastrointestinal Stromal Tumors

Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life Experience

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

Suchergebnisse filtern